Haisco Pharmaceutical Group Co., Ltd.
SHZ: 002653.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Xiu Lian Fan
- Employees
- 5,337
- Headquarters
- Shannan, China
- IPO year
- 2012
- Market cap
- CN¥61.3B
- Website
- https://www.haisco.com
Loading 002653…
Loading profile data…Frequently asked questions about 002653
What does Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) do?
Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive sys...
Where does 002653.SZ trade?
Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002653.SZ in?
Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Haisco Pharmaceutical Group Co., Ltd.?
Xiu Lian Fan is the chief executive officer of Haisco Pharmaceutical Group Co., Ltd. (002653.SZ).
Where is Haisco Pharmaceutical Group Co., Ltd. headquartered?
Haisco Pharmaceutical Group Co., Ltd. is headquartered in China.
Does 002653.SZ pay a dividend?
Yes — Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) paid a trailing twelve-month dividend of CNY 0.14 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002653.SZ go public?
Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) completed its initial public offering in 2012.